For UK patients, and their caregivers, aged 12 and over who have been prescribed Tezspire (tezepelumab) for severe uncontrolled asthma

For more information read the patient information leaflet accessible here

  • Home
  • About Tezspire
    What is Tezspire? How does it work? Why were you
    prescribed Tezspire?
  • How to use Tezspire
  • Safety and side effects
  • Resources
  • FAQs

For UK patients, and their caregivers, aged 12 and over who have been prescribed Tezspire▼ (tezepelumab) for severe uncontrolled asthma

For more information read the patient information leaflet accessible here

  • Home
  • About Tezspire
  • How to use Tezspire
  • Safety and side effects
  • Resources
  • FAQs
  • close
menu

About Tezspire: understanding Tezspire as a treatment for your severe asthma

Tezspire is a medicine that helps people aged 12 and older to manage their severe asthma. It is an add-on maintenance treatment which means that you use it with other asthma medicines to treat severe asthma when the disease isn't under control with these other medicines.

Tezspire works in a different way to your other asthma medicines which is why it may help to: reduce asthma attacks, improve your breathing and ease your asthma symptoms.

You may have heard your doctor call Tezspire 'tezepelumab' as this is the name of the active substance it contains. When triggered, your immune system makes special proteins called 'antibodies' to defend you against harmful substances, like a virus. Tezepelumab is a monoclonal antibody, which means it’s made in a lab, but it works in a similar way to our immune system's natural antibodies.

Tezspire specifically targets a substance called TSLP (thymic stromal lymphopoietin). Find out more about why TSLP is important below.

Tezspire targets a protein released by our immune system, called TSLP which plays a key role in causing inflammation in your airways leading to signs and symptoms of asthma. Tezspire blocks the action of TSLP, to help reduce inflammation and asthma symptoms.

The way Tezspire works*

Multiple external triggers, such as pollen, dust mite and cat dander cause the release of TSLP.

TSLP plays a role in causing inflammation in your airways that
leads to signs and symptoms of asthma.

By blocking the action of TSLP, Tezspire helps to reduce inflammation and asthma symptoms.

*The exact mechanism by which Tezspire works has not been established.

Your doctor will have prescribed you Tezspire because your severe asthma was not under control even though you were taking other asthma medicines. Tezspire may help to: reduce asthma attacks, improve your breathing, and ease your asthma symptoms.

Things you should know before starting your Tezspire treatment

 

How to use and store Tezspire

Reporting side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.ukhttps://yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get as advised above.

GB-49705 | DOP: February 2024

This is a non-promotional website produced and funded by AstraZeneca.

This site is intended to complement, not replace, the 'Instructions for Use' and 'Patient Information Leaflet' (found in your carton or linked at the top of the page). Refer to these materials for additional important information.

If you have any questions or concerns about your treatment, you should always talk to your healthcare team.

Please see the information in the box above for details on how to report any side effects you may be experiencing.

Tezspire is a registered trademark of the AstraZeneca group of companies

©2024 AstraZeneca All rights reserved. GB-49703 Date of Preparation: March 2024

Legal notice | Privacy policy | Contact us | Cookie policy

Welcome to an AstraZeneca UK produced and funded website

Please select the option that applies to you below.

FOR UK HEALTHCARE PROFESSIONALS

If you are a UK HCP and would like to access information on
Tezspire (tezepelumab), please enter the site using the button below.

This is a promotional website.

FOR UK PATIENTS
OR CARERS

If you are a UK patient, or their carer, prescribed Tezspire (tezepelumab), please enter the site using the button below.

FOR THE GENERAL
PUBLIC

If you are not a UK HCP or
Tezspire (tezepelumab) patient/ carer, this website is not suitable for you.

GB-51556 | DOP: March 2024

Visit astrazeneca.co.uk